Join CBMTG | Print Page | Contact Us | Sign In
CBMTG 2018 ANNUAL CONFERENCE PRESENTATIONS

To view or download the presentations from the 2018 CBMTG Annual Conference in Ottawa, ON, please click on the links below.


Wednesday, June 6, 2018 – Pre-Conference

LEADERSHIP TRAINING: DEVELOPING STRATEGIC FOCUS IN YOUR LIFE

Peter Craighead, MD, ChB
 
BMT 101

Matching Stem Cell Products to Patient Needs
David Allan, MD, FRCPC

The Hematopoietic Cell Transplantation Conditioning Regimen
Chris Bredeson, MD, MSc, FRCPC

Infectious Disease Evaluation in the Pre-Transplant Patient
C. Arianne Buchan, MD, FRCPC

Chronic GVHD 101
Donna Wall, MD, CCPE

Introduction to CAR-T Cells
Natasha Kekre, MPH, MD, FRCPC

 


Thursday, June 7, 2018

Session 1

From the Beginnings to Now and Beyond: The CBMTG Story
Lothar Huebsch, MD, FRCPC

Autologous Hematopoietic Stem Cell Transplantation for Immune Repair in Autoimmune Diseases
Harold Atkins, MD, FRCPC

CD34 Selection Past, Present and Future
Sergio Giralt, MD

 
SESSION 2A: SCIENCE

Till and McCulloch Lectureship: Stem Cell Engineering to Improve Blood Stem Cell Transplantation
Peter Zandstra, PhD, FRSC, PEng

Exercise as an Adjuvant Therapy For Hematopoietic Stem Cell Transplant
Michael De Lisio, PhD

Anti-Minor Histocompatibility Antigen Immunotherapy
Denis Claude-Roy, MD, FRCPC

 
SESSION 2B: NURSING

Nursing Management of Chronic GVHD – The Good, the Bad and the Ugly
Tammy De Gelder, RN(EC), MN-NP(adult), CON (C)

How to Manage Patients Undergoing Out-Patient CD19-CAR-T Therapy
Ronan Foley,MD, FRCPC, and Jennifer Wiernikowski, MN, NP-Adult, CON(C)

Refractory Leukemia: To Transplant or Not
Mitchell Sabloff, MSc, MDCM, FRCPC

 
SESSION 2C: LABORATORY

Cord Blood Updates:

Canadian Blood Services
Heidi Elmoazzen, PhD

The Héma-Québec CBB
Diane Fournier, PhD

Clinical Updates
Donna Wall, MD

GMP on a Shoestring, a Cost Effective Manufacturing Model
Qingdong Guan, PhD

CAR-T Cells in Canada: a New Model to Achieve Sustainability While Fostering Innovation
Brad Nelson, PhD

Regenerative Medicine is in Motion: Are You Ready?
Linda Peltier, PhD

 
SESSION 2D: PHARMACY

Management of Steroid Refractory GVHD
Raewyn Broady, MBChB, FRACP, FRCPC

No One Can Whistle a Symphony - Improving Collaboration Amongst Canadian BMT Pharmacists
Jennifer Jupp, BScPharm, BCOP

The Condition of the Conditioned: Preparative Regimes in the Elderly
Mark Brown, PharmD

 


Friday, June 8, 2018

SESSION 3: REGISTRIES AND TRANSPLANT

HCT in 2018: Where are We and Where are We Going?
Mary Horowitz, MD, MS

 
SESSION 4: NAVIGATING BMT AND CELLULAR THERAPY WITHIN THE CANADIAN HEALTH CARE SYSTEM

Regulation of Cell and Gene Therapies
Nadine Kolas, PhD

Choosing Wisely: Blood and Marrow Transplant
Matthew Seftel, MD, MPH, FRCP, FRCPC

Exploiting Science? Complementary and Alternative Medicine Clinics’ Marketing of Unproven Stem Cell Therapies
Blake Murdoch, JD, MBA

 


Saturday, June 9, 2018

SESSION 5A: SPECIAL TOPICS IN ADULT TRANSPLANT

Measurable Residual Disease in Patients with Acute Myeloid Leukemia Undergoing Transplantation
David Sanford, MD,FRCPC

Maintenance Therapy After Autologous Transplant for Lymphoma
Doug Stewart, MD, FRCPC

 
SESSION 5B: SPECIAL TOPICS IN PEDIATRIC TRANSPLANT
DEBATE: What is the Best Approach for Haploidentical Transplant in BMT?

Ex-vivo Cell Depletion
Mary Slatter, MBChB, FRCPCH

Ex-vivo Cell Depletion versus In-vivo Depletion (PTCy)
Heather Symons, MD, MHS

Fred Saunders Lectureship: Chronic GvHD Biomarkers: A Window to Immune Tolerance and Cancer Immune Therapy
Kirk R. Schultz, MD

 
SESSION 6: DONOR CHOICE FOR ALLOGENEIC TRANSPLANT
DEBATE: Alternative Donor Choice in Allogeneic Transplant

Related Haploidentical Donors are the Best Choice
Mohamad Mohty, MD, PhD

Unrelated Adult Donors are Preferred
Chris Bredeson, MD, MSc, FRCPC

Cord Blood Donors: Engineering the Graft of the Future
Sandra Cohen, MD, FRCPC

This website is sponsored by an unrestricted educational grant from:

Follow CBMTG